Menu

Blog

Jul 24, 2020

Moderna loses challenge to Arbutus patent on vaccine technology

Posted by in category: biotech/medical

(Reuters) — Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine.

0 comments

Comments are closed.

Tag cloud

aging AI Alzheimer's anti-aging Artificial Intelligence bioquantine bioquark biotech biotechnology bitcoin blockchain brain death cancer cryptocurrency culture Death existential risks extinction future futurism Google health healthspan humanity ideaxme immortality Interstellar Travel ira pastor Life extension lifespan longevity NASA Neuroscience politics reanima regenerage regeneration research risks singularity space sustainability technology transhumanism wellness

Categories